The correlation between MDSCs, cancer, immunotherapy, and IL-22

Cancer is one of modern society's most prolific killers. Treatments develop slowly, and their efficiency varies from person to person. A promising new treatment is immunotherapy. However, cancer is made of self cells, which take advantage of the body's own machinery. That machinery includes MDSCs, which work to suppress the immune system.


This project is based on a foundation of pre-established research and data.

An Overview of MDSCs

MDSCs are a very important part of the immune system that acts as a system of checks and balances.

Cancer and the faults of immunotherapy

Cancer is a terrible, terrible disease with no perfect treatment. Immunotherapy is a potentially effective treatment, but it has many faults and setbacks that are yet to be studied.

Interleukin 22 (IL-22)

IL-22 is an inflammatory cytokine that may play a large part in how cancer progresses. It is the focus of this research.

©2019 by Anjali Kalagiri. Proudly created with Wix.com

This site was designed with the
website builder. Create your website today.
Start Now